EMEA-001344-PIP02-17

Key facts

Invented name
  • Zenon
  • Suvezen
Active substance
  • Ezetimibe
  • Rosuvastatin
Therapeutic area
Cardiovascular diseases
Decision number
P/0126/2018
PIP number
EMEA-001344-PIP02-17
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Prevention of cardiovascular events
Route(s) of administration
Oral use
Contact for public enquiries
Zentiva, k.s.
Tel.: +420 267243574
E-mail: blanka.zoubkova@sanofi.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating